Can exercise boost a Weight-Loss drug? new study aims to find out

NCT ID NCT07298915

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding exercise to the weight-loss medication tirzepatide helps people lose more weight and improve health markers like blood sugar and cholesterol. Researchers will enroll 24 adults aged 30–65 with overweight or obesity. Participants will take tirzepatide for 16 weeks, and some will also do supervised aerobic and resistance training three times a week.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tirzepatide and exercise
What this could lead to
If it works, this could show that combining exercise with weight-loss medication leads to greater fat loss and better heart health than medication alone.
What could go wrong
This is a small, early-phase trial with only 24 people, so results may not apply to everyone. Exercise adherence can be low, and tirzepatide may cause side effects like nausea.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Virginia

    Charlottesville, Virginia, 22901, United States

    Contact

    Contact Phone: •••-•••-••••

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.